Clonidine for smoking cessation

Gourlay, Steven G.; Stead, Lindsay F; Benowitz, Neal L.

doi:10.1002/14651858.cd000058.pub2

Cited by 158 publications

(104 citation statements)

References 28 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Forty-one systematic reviews were identified, of which 12 focused on pharmacotherapies for smoking cessation. [138][139][140][144][145][146][147][148][149][150][151][152] The 12 systematic reviews were screened to identify studies that assessed specific pharmacotherapies with evidence of effectiveness. The full texts of the papers identified from the included Cochrane reviews were then screened independently by two authors (JL-B and SA or AMcN and TC) using a specially designed data extraction form to assess whether they fulfilled the pre-specified inclusion criteria (see Box 7, Figure 16).…”

Section: Process For Identifying Studiesmentioning

confidence: 99%

Relapse prevention in UK Stop Smoking Services: current practice, systematic reviews of effectiveness and cost-effectiveness analysis.

Coleman

Agboola²,

Leonardi‐Bee³

et al. 2010

Health Technol Assess

View full text Add to dashboard Cite

How to obtain copies of this and other HTA programme reports An electronic version of this title, in Adobe Acrobat format, is available for downloading free of charge for personal use from the HTA website (www.hta.ac.uk). A fully searchable DVD is also available (see below).Printed copies of HTA journal series issues cost £20 each (post and packing free in the UK) to both public and private sector purchasers from our despatch agents.Non-UK purchasers will have to pay a small fee for post and packing. For European countries the cost is £2 per issue and for the rest of the world £3 per issue. How to order:-fax (with credit card details) -post (with credit card details or cheque) -phone during office hours (credit card only).Additionally the HTA website allows you to either print out your order or download a blank order form. Contact details are as follows:Synergie UK (HTA Department) Digital House, The Loddon Centre Wade Road Basingstoke Hants RG24 8QW Email: orders@hta.ac.uk Tel: 0845 812 4000 -ask for 'HTA Payment Services' (out-of-hours answer-phone service) Fax: 0845 812 4001 -put 'HTA Order' on the fax header Payment methods Paying by chequeIf you pay by cheque, the cheque must be in pounds sterling, made payable to University of Southampton and drawn on a bank with a UK address. Paying by credit cardYou can order using your credit card by phone, fax or post. SubscriptionsNHS libraries can subscribe free of charge. Public libraries can subscribe at a reduced cost of £100 for each volume (normally comprising 40-50 titles). The commercial subscription rate is £400 per volume (addresses within the UK) and £600 per volume (addresses outside the UK). Please see our website for details. Subscriptions can be purchased only for the current or forthcoming volume. How do I get a copy of HTA on DVD?Please use the form on the HTA website (www.hta.ac.uk/htacd/index.shtml). HTA on DVD is currently free of charge worldwide.The website also provides information about the HTA programme and lists the membership of the various committees. HTA Relapse prevention in UK Stop Health Technology Assessment is indexed and abstracted in Index Medicus/MEDLINE, Excerpta Medica/EMBASE, Science Citation Index Expanded (SciSearch) and Current Contents / Clinical Medicine. NIHR Health Technology Assessment programmeT he Health Technology Assessment (HTA) programme, part of the National Institute for Health Research (NIHR), was set up in 1993. It produces high-quality research information on the effectiveness, costs and broader impact of health technologies for those who use, manage and provide care in the NHS. 'Health technologies' are broadly defined as all interventions used to promote health, prevent and treat disease, and improve rehabilitation and long-term care. The research findings from the HTA programme directly influence decision-making bodies such as the National Institute for Health and Clinical Excellence (NICE) and the National Screening Committee (NSC). HTA findings also help to improve the quality of clinical practice in t...

show abstract

Section: Process For Identifying Studiesmentioning

confidence: 99%

Relapse prevention in UK Stop Smoking Services: current practice, systematic reviews of effectiveness and cost-effectiveness analysis.

Coleman

Agboola²,

Leonardi‐Bee³

et al. 2010

Health Technol Assess

View full text Add to dashboard Cite

show abstract

“…Meta-analyses (table 1) indicate that various pharmacological treatments improve SC: nicotine replacement therapy, substitutes of nicotine [64,65,66,67,68,69], bupropion and nortriptyline (antidepressants) [67,70,71,72,73,74], and varenicline, cytisine and mecamylamine (agonists of the nicotine acetylcholine receptors) [67,75,76,77,78]. Naltrexone, an opioid antagonist, has no significant impact on SC [79].…”

Section: Resultsmentioning

confidence: 99%

Environmental and Genomic Factors as well as Interventions Influencing Smoking Cessation: A Systematic Review of Reviews and a Proposed Working Model

Viron¹,

Malats²,

Heyden³

et al. 2013

Public Health Genomics

View full text Add to dashboard Cite

Background: Smoking behaviour is a major public health problem worldwide. Several sources have confirmed the implication of genomic factors in smoking behaviour. These factors interact both with environmental factors and interventions to develop a certain behaviour. Objectives: Describing the environmental and genomic factors as well as the interventions influencing smoking cessation (SC) and developing a working model incorporating the different factors influencing SC were our main objectives. Methods: Two systematic reviews were conducted using articles in English from the Cochrane library, PubMed and HuGENet from January 2000 to September 2012: (1) a systematic review of systematic reviews and meta-analyses and (2) a systematic review of original research for genomic factors. The proposed working model was developed by making use of previous models of SC and applying an iterative process of discussion and re-examination by the authors. Results: We confirmed the importance of the 4 main factors influencing SC: (1) environmental factors, (2) genomic factors, (3) gene-environment interactions, and (4) evidence-based interventions. The model demonstrates the complex network of factors influencing SC. Conclusion: The working model of SC proposed a global view of factors influencing SC, warranting future research in this area. Future testing of the model will consolidate the understanding of the different factors affecting SC and will help to improve interventions in this field.

show abstract

“…Vareniklin dapat menyebabkan gejala gastrointestinal (mual, konstipasi, dispepsia, muntah), sakit kepala, insomnia, mimpi buruk [11]. Klonidin dapat menyebabkan mulut kering dan sedasi [12]. Faktor biaya juga merupakan masalah yang dapat ditimbulkan pada proses terapi obat untuk pemberhentian merokok.…”

Section: Pendahuluanunclassified

Persepsi, Efektifitas, dan Keamanan Penggunaan Rokok Elektrik (E-Cigarette) oleh Perokok Aktif sebagai Terapi dalam Smoking Cessation: Mixed Methods dengan Pendekatan Studi Kuantitatif dan Kualitatif

Lorensia

Yudiarso

Herwansyah

2017

J. Trop. Pharm. Chem.

View full text Add to dashboard Cite

Cigarettes is one of the biggest causes of health problems in the world. Disadvantages in terms of health and economy is then the program to stop smoking (smoking cessation) ABSTRAKRokok merupakan salah satu faktor penyebab gangguan kesehatan terbesar di dunia. Kerugian dalam hal kesehatan dan ekonomi tersebut maka program berhenti merokok (smoking cessation) menjadi pilihan utama pengobatan bagi perokok. Kini banyak perokok beralih menggunakan rokok elektrik (e-cigarette) yang meningkat pesat perkembangannya. Penelitian ini bertujuan untuk menggali lebih dalam mengenai persepsi, efektifitas dan keamanan penggunaan rokok elektrik oleh perokok aktif dalam usahanya untuk berhenti merokok. Desain penelitian ini menggunakan mix method, dengan tahap metode deskriptif dan tahap interpretatif phenomenologi analysis (IPA) dalam mengamati persepsi, efektifitas, dan keamanan. Responden yang terlibat sebanyak 47 orang, yaitu pengguna rokok elektrik yang sebelumnya pernah menggunakan rokok biasa (tembakau). Hasil penelitian menunjukkan partisipan menganggap rokok elektrik efektif membantu dalam proses smoking cessation. Rokok eletrik terbukti mengurangi frekuensi penggunaan rokok tembakau (25%) dan menyebabkan berhenti merokok (75%). Sedangkan sebagian besar responden tidak mengalami efek samping (66,66%), dan efek yang dilaporkan adalah tenggorokan terasa kering dan batuk (33,33%). Kesimpulannya rokok elektrik diyakini mampu membantu proses smoking cessation walaupun efektifitas dan keamanannya masih membutuhkan penelitian lebih lanjut.

show abstract

Clonidine for smoking cessation

Abstract: Transdermal Nicotine Study Group. Transdermal nicotine for smoking cessation. Six-month results from two multicenter controlled clinical trials.

Cited by 158 publications

References 28 publications

Relapse prevention in UK Stop Smoking Services: current practice, systematic reviews of effectiveness and cost-effectiveness analysis.

Relapse prevention in UK Stop Smoking Services: current practice, systematic reviews of effectiveness and cost-effectiveness analysis.

Environmental and Genomic Factors as well as Interventions Influencing Smoking Cessation: A Systematic Review of Reviews and a Proposed Working Model

Persepsi, Efektifitas, dan Keamanan Penggunaan Rokok Elektrik (E-Cigarette) oleh Perokok Aktif sebagai Terapi dalam Smoking Cessation: Mixed Methods dengan Pendekatan Studi Kuantitatif dan Kualitatif

Contact Info

Product

Resources

About